Template:DrugProjectFormSinglePage: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 161: | Line 161: | ||
There is no FDA guidance on usage of {{PAGENAME}} in women who are pregnant. | There is no FDA guidance on usage of {{PAGENAME}} in women who are pregnant. | ||
}} | }} | ||
'''[[Pregnancy category#Australia|Pregnancy Category (AUS)]]: {{{AUSPregCat|}}}''' | '''[[Pregnancy category#Australia|Pregnancy Category (AUS)]]: {{{AUSPregCat|}}}''' | ||
{{#if: {{{useInPregnancyAUS|}}} | | {{#if: {{{useInPregnancyAUS|}}} | | ||
{{{useInPregnancyAUS|}}} | | {{{useInPregnancyAUS|}}} |<BR> | ||
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant. | There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant. | ||
}} | }} |
Revision as of 17:10, 1 August 2017
This is the "Drug Project Form" template. It should be called in the following format:
{{DrugProjectForm |authorTag= |genericName= |drugClass= |indication= |indicationType= |commonAdverseReactions= |hasBlackBoxWarning= |blackBoxWarningTitle= |blackBoxWarningBody= |fdaLIADAdult= |offLabelAdultGuideSupport= |offLabelAdultNoGuideSupport= |fdaLIADPed= |offLabelPedGuideSupport= |offLabelPedNoGuideSupport= |contraindications= |warnings= |adverseReactions= |clinicalTrials= |postmarketing= |drugInteractions= |FDAPregCat= |useInPregnancyFDA= |AUSPregCat= |useInPregnancyAUS= |useInLaborDelivery= |useInNursing= |useInPed= |useInGeri= |useInGender= |useInRace= |useInRenalImpair= |useInHepaticImpair= |useInReproPotential= |useInImmunocomp= |othersTitle= |useInOthers= |administration= |monitoring= |IVCompat= |overdose= |drugBox= |mechAction= |structure= |PD= |PK= |nonClinToxic= |clinicalStudies= |howSupplied= |NDC= |storage= |manBy= |distBy= |drugImages= |packLabel= |fdaPatientInfo= |nlmPatientInfo= |alcohol= |brandNames= |lookAlike= |drugShortage= |price= }}
Edit the page to see the template text.